Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 17. November 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9151  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 183019  
   
Healthy lifestyle adherence and insulin resistance in prostate cancer patients undergoing radiotherapy: baseline findings from the MicroStyle study.
Eur J Cancer Prev
Doi G, Bellerba F, Repetti I, Mazzocco K, Marvaso G, Gnagnarella P, Summa B, Ciceri S, Carioni G, Johansson H, Macis D, Aristarco V, Lorubbio C, Luzzago S, Musi G, Pravettoni G, Milani A, Borzillo V, Crispo A, Porciello G, Grimaldi M, Pinto M, Cavalcanti E, Fodor CI, Jereczek-Fossa BA, Gandini S, MicroStyle Collaborative Group.
PMID: 43040935 [PubMed - as supplied by publisher]


Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High-Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study.
Int J Urol
Washino S, Kaneko G, Sazuka T, Nagamoto S, Nakamura Y, Nakayama A, Mito K, Kazashi K, Saito K, Takeuchi S, Yano A, Miyagawa T.
PMID: 43040843 [PubMed - indexed for MEDLINE]


Preoperative frailty and multidimensional concurrent correlates among older adults scheduled for radical cystectomy: a social ecological model-informed cross-sectional study.
BMC Urol
Yan Y, Wang L, Zhou Y, Wang X, Jiang Q, Lu T, Ma H, Qian J.
PMID: 43040474 [PubMed - indexed for MEDLINE]


Ultrasound imaging characteristics of renal epithelioid angiomyolipoma.
BMC Med Imaging
Mu J, Mao Y, Zhao L, Jia J, Wang H, Wei X.
PMID: 43040316 [PubMed - indexed for MEDLINE]


ASO Visual Abstract Peritumoral CT Features Improve the Prediction of Nuclear Grade in Small (2-4 cm) Solid Clear Cell Renal Cell Carcinoma: A Multicenter Study.
Ann Surg Oncol
Song X, Li X, Sun F, Wang Y, Sun D, Zhang W, Zheng Z, Zhang S, Li W, Qu J.
PMID: 43040171 [PubMed - as supplied by publisher]


Gene expression analyses of immune tumor microenvironment in advanced renal cell carcinoma patients based on response to immunotherapy (Meet-URO 18 I-TME study).
Cancer Immunol Immunother
Rebuzzi SE, Catalano F, Schiavi F, Buti S, Rescigno P, Maruzzo M, Masini C, Zatteri L, Spada M, Signori A, Conteduca V, Banna GL, Puglisi S, Rossi S, Pinato C, Di Costanzo F, Dei Tos AP, Brunelli M, Fornarini G, Galuppini F.
PMID: 43040155 [PubMed - indexed for MEDLINE]


Robotic-assisted versus open radical nephrectomy with inferior vena cava thrombectomy for renal cell carcinoma: a systematic review and meta-analysis of perioperative outcomes and oncological endpoints.
Clin Transl Oncol
Villalobos-Almanza D, Salazar-Monroy A, Olvera-Posada D.
PMID: 43040134 [PubMed - as supplied by publisher]


Phase I trial of using a prostatic urethral lift implant with stereotactic ablative body radiotherapy for men with prostate cancer and benign prostatic hyperplasia (NCT05311527).
Prostate Cancer Prostatic Dis
Kwon YS, Kudchadker R, Desai NB, Hannan R, Lee M, Mauck R, Tse J, Gaston K, Dickinson T, Rezaie S, Hornberger B, Yang D, Ibarra M, Morgan H, Park YK, Gonzalez Y, Roehrborn C, Timmerman R, Woldu S, Garant A.
PMID: 43039975 [PubMed - as supplied by publisher]


Clinically Presumed Brain Metastasis as the Initial Presentation of Prostate Cancer Harboring a BRCA2 Alteration With Subsequent Transformation to Treatment-Related Neuroendocrine Prostate Cancer: A Case Report.
Cancer Rep (Hoboken)
Wang Y, Wu Y, Zhu S, Wu Z, Dang Q.
PMID: 43039876 [PubMed - indexed for MEDLINE]


Which Patients with Advanced Clear Cell Renal Cell Carcinoma Benefit Most from First-line Checkpoint Inhibitor Combination Regimens: A Meta-analysis of Individual Patient Data and Aggregate Data from Randomised Trials.
Eur Urol
Richters A, Westgeest HM, Özdemir BC, Bond MJG, Damen JAA, Aben KKH, Bex A.
PMID: 43039767 [PubMed - as supplied by publisher]


Early Real-World Outcomes and Safety of Belzutifan in Japanese Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
Takeuchi K, Okamoto T, Sekine Y, Shinohara M, Tamaki G, Abe N, Kobayashi S, Fujita N, Sato S, Habuchi T, Hatakeyama S, Numakura K.
PMID: 43039759 [PubMed - as supplied by publisher]


Time to nephrectomy in pathological T stage (pT)1b-2 renal cancer and the decision made at diagnosis.
BJU Int
Luo H, Ye T.
PMID: 43039643 [PubMed - as supplied by publisher]


Prostate Cancer and PSMA PET/CT.
Magn Reson Imaging Clin N Am
Arca B, Sanli Y.
PMID: 43039506 [PubMed - indexed for MEDLINE]


MR Clinics-Nuclear Medicine in Renal, Adrenal, Bladder and Urothelial Malignancies.
Magn Reson Imaging Clin N Am
Romsa J, Sutherland D, Akincioglu C.
PMID: 43039504 [PubMed - indexed for MEDLINE]


Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in Prostate Cancer: Patient Selection, Treatment Workflow, and Emerging Directions.
Magn Reson Imaging Clin N Am
Denizmen Zorba D, Sanli Y.
PMID: 43039498 [PubMed - indexed for MEDLINE]


INTERMITTENT ANDROGEN DEPRIVATION THERAPY PLUS COMPREHENSIVE STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC HORMONE SENSITIVE PROSTATE CANCER (CROP): MATURE RESULTS OF A PROSPECTIVE TRIAL.
Int J Radiat Oncol Biol Phys
Cheung P, Tseng CL, Chung H, Chu W, Vesprini D, Liu S, Sahgal A, Soliman H, Myrehaug S, Detsky J, Chung P, Helou J, Emmenegger U, Escueta V, Mamedov A, Zhang L, Morton G, Loblaw A.
PMID: 43039250 [PubMed - as supplied by publisher]


Tumor-associated neutrophil heterogeneity in prostate cancer: functional plasticity, phenotypic states, and therapeutic implications.
Transl Oncol
Melchior F, Salcher S, Pircher A, Heidegger I.
PMID: 43038767 [PubMed - as supplied by publisher]


Quality-of-life outcomes of MR-guided ultrahypofractionated SBRT versus CBCT-guided moderately hypofractionated IMRT for localized prostate cancer: an EPIC-based real-world comparative study.
Jpn J Clin Oncol
Shirafuji T, Yamada Y, Saito M, Amemiya Y, Horikoshi T, Kubota Y, Sato K, Tamura T, Kurozumi A, Saito S, Ando K, Sazuka T, Imamura Y, Uno T, Sakamoto S.
PMID: 43038029 [PubMed - as supplied by publisher]


Study Rationale, Enrollment Characteristics, and Central Review of Clinical Stage: The INTACT Randomized Clinical Trial.
JAMA Netw Open
Singh P, Plets M, Efsthathiou J, Jhavar SG, Tangen C, Delacroix S Jr, Marquette C, Mouw KW, Khalil MF, Ballas LK, Sachdev S, Johnson BA 3rd, Jani A, Cross B, Grivas P, Palopoli J, Kirchner A, Shen X, Parikh M, Olson A, Mehan P, Costello B, Joshi M, Daneshmand S, Petrylak D, Thompson I, Nguyen PL, Lerner SP.
PMID: 43037986 [PubMed - indexed for MEDLINE]


Evaluating Artificial Intelligence Chatbots for Patient Education on Prostate Biopsy in the Prostate Cancer Diagnostic Pathway.
J Cancer Educ
Olgun A, Zengin S.
PMID: 43037951 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 183019    Seite 1 von 9151  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1